Introduction
Heparan sulphate (HS) is the major glycosaminoglycan on mammalian cell surfaces and in basement membranes [1,2]. Cell surface HS is attached covalently to two major classees of protein, the transmembrane syndecans and the glycosylphosphatidylinositol (GP1)-anchored glypicans and in basement membranes the principle component that bears HS is a large multidomain protein called perlecan. These protein cores typically contain 2-3 HS chains positioned in close proximity to each other along a short stretch of peptide in which the glycanated serine residues are in sequences of short Ser-Gly repeats with hydrophobic and acidic amino acids in the vicinity of the glycanation region [3]. This clustering of HS chains is suggestive of a co-operative mode of action which may be of special relevance to the role of HS-proteoglycans in regulating cell adhesion and migration on biomatrices.
Biosynthesis and structure of H S
In common with most other glycosaminoglycans, HS is linked to core proteins by a tetrasaccharide sequence at the reducing end of the chain comAbbreviations used: €IS, heparan sulphate; GPI, glucosylphosphatidylinositol; IdoA, iduronate; bFGF, basic fibroblast growth factor; aFGF, acidic fibroblast growth factor; AT-111, anti-thrombin 111.
posed of Xyl-Gal-Gal-GlcA-with the xylose in an 0-glycosidic linkage to serine. T h e polymer is built up on this linkage sequence by the addition of GlcNAc and GlcA in alternate sequence to form polysaccharides ranging in length from 50 to 200 GlcNAc-GlcA disaccharide repeats.
During polynierization enzyme-mediated modifications to the growing 'heparan' chain [4] are initiated beginning with the conversion of a proportion (normally 40-50%) of the GlcNAc units to the unique N-sulphated glucosamine (GlcNSOJ catalysed by deacetylase/ N-sulphotransferase enzymes. Further modifications include the epimerization of GlcA to the C-5 epimer iduronate (IdoA) followed by the addition of sulphate groups to C-2 of IdoA, C-6 of the amino sugars, and more rarely to C-3 of GlcNS03. These modifications are confined to regions of N-sulphation and are largely excluded from areas where N-acetylated disaccharides predominate. This restriction acts as a constraint on the sequence variability seen in HS [5] and leads to the formation of domains of relatively high sulphation (S-domains) and IdoA content. These S-domains arise because the primary changes in HS synthesis (i.e. conversion of GlcNAc into GlcNSOJ are mainly directed to localized areas of the polymer chain [6, 7] rather than being uniformly distributed (Figure 1 ). T h e S-domains are thus separated by relatively unmodified N-acetyl-rich regions which act as spacers giving Volume 25 the HS chain its distinctive character from the chemically related heparin which is made up almost entirely of N-sulphated disaccharide units [8] . For a thorough review of HS and heparin synthesis see [4] .
HS messages in the sequence
Anticoagulation and polymorphism HS plays many important roles in the biology and biochemistry of the cell. It is well recognized that HS is important in maintaining a non-thrombogenic surface on the endothelial lining of blood vessels due to the presence of a unique pentasaccharide sequence (first identified in anticoagulant heparin) of the following structure:
G~cNAc,~S-G~CA-G~CNSO~,~S-I~OA,~S-G~CNSO~,~S
This sequence binds to anti-thrombin 111 (AT-111) with high affinity and greatly accelerates the rate at which it binds and inhibits
Figure I
Domain structure of HS HS consists of hypervariable sulphated domains (S domains) separated by regions of low sulphation (spacer regions). The S-domains contain the majority of N-and 0-sulphate groups and ldoA residues, whereas N-acetylated disaccharides predominate in the spacer regions. The enzyme heparitinase (favoured substrate GlcNAc/GlcNSO,-GlcA) can be used to release the S-domains (typical size range 2-7 disaccharides), whereas heparinase cuts HS within the S-domains at the GlcNS03( k6S)-
IdoA,ZS linkage. The above model, although giving a simplified view of HS, is applicable to the majority of HS polymers produced by different cell types. Variations in sulphation pattern, particularly involving the 0-sulphate groups, are superimposed on a common S-domain organization to give rise to cell-type-specific HS species. Rat liver HS is the major exception to the spaced arrangement of S-domains: the liver HS contains on average three S-domains in close apposition in the distal region of the chain @].
-7 % core protein = -GlcNSO3(*6SWdoA,2S Hepnrinase 1 -= GlcNAc, GlcA > GlcNSO, GlcA 4 Heparitinase 4 thrombin and factor Xa [9, 10] . It is noteworthy that an unmodified sugar (GlcA) is present at residue 2 and the rare 3-0-sulphate is present on the GlcNS03 at residue 3. A GlcNAc residue at position 1 is not absolutely required (GlcNS03 will suffice) but it inhibits any tendency for the adjacent GlcA to be converted into IdoA; the 6-0-sulphate group on the GlcNAc is vital for AT-I11 binding. The AT-111-binding pentasaccharide sequence is thus brought about by the concerted action of a number of enzymes which effect an incomplete but controlled set of modifications to short sections of the HS/heparin chain. This reflects the clearly observed fact that in HS (and in heparin also) the potential for epimerization and sulphation of N-sulphated regions is never fully realized and a particularly notable feature of HS is that although its fine structure varies from one cell type to another, this variation is largely due to different levels of 0-sulphation imposed on a common backbone structure of spatially discrete S-domains ( Figure  1 ). The AT-I11 binding sequence may be considered as a distinct short region at the interface of an S-domain with an N-acetyl-rich spacer.
I207 S-domains: molecular size, sulphation and growth control
The S-domains in HS vary in size from two to about seven or eight disaccharide units, although occasionally even longer domains are found. The S-domains are designed for protein recognition and their fine structure and positioning along the HS chain are important aspects of their recognition properties. Examples of the importance of S-domain spacing have come from studies of interferon y and platelet factor 4 (dimeric and tetrameric proteins respectively) which span S-domains separated by about 10-12 disaccharide units [11, 12] . Basic and acidic fibroblast growth factor (bFGF and aFGF respectively) both require HS for their biological activity [I31 and although the mode of action of HS is obscure it is likely that some form of conformational change is induced in the growth factors which enables them to bind in a productive manner to their signal-transducing receptors [14] . One popular view is that an active site on HS will bind two FGFs, which interact directly with each other to form a dimeric, receptor-binding ligand [ 15,161.
The detailed structure of the high-affinity binding site for bFGF in HS has been studied by several groups. There is a general consensus that activation of bFGF requires S-domains of 6-7 N-sulphated disaccharide units with IdoA residues and 2-0-sulphate groups being major features of the binding region [17, 18] . An S-domain of seven disaccharides was isolated from fibroblast HS using the enzyme heparitinase (Figure 1) . The S-domain was named oligo-H, and it contained a highly regular internal repeat unit of the following sequence:
The sequence was devoid of 6-0-sulphate groups but it still bound to bFGF with a similar affinity to that of the parent HS [19] . When this sequence was first identified it was unclear whether it contained all the structural features required to promote the activity of bFGF. If it was not an activating sequence, then what was its purpose? Oligo-H was much longer than a pentasaccharide sequence proposed to be the minimal binding site for bFGF [20] ; this structure contained a single IdoA,2S in the sequence:
HexA-Gl~NS0~-HexA-GlcNS0~-1doA,2S
where the HexA could be GlcA or IdoA. The presence of 6-sulphates was not required for binding of such short saccharides and this view was confirmed by studies on the crystal structures of heparin tetra-and hexa-saccharides and bFGF [21] . The N-sulphate groups and IdoA,2S in this pentasaccharide were shown to be important for binding to bFGF, but short sequences of the above type do not activate the growth factor. This may imply that the requirement for longer sequences reflects the need to bind two bFGFs in a single site as already discussed.
Studies on N-sulphated saccharides derived from heparin (i.e., IdoA,2S-GlcNS03,6S repeat units) and on selectively desulphated derivatives supported the view that 2-0-sulphate and N-sulphate groups were important for bFGF binding, with no obvious role for 6-sulphates [ 181; however, 6-sulphate groups were needed for bFGF activation [18] , and it was concluded that the active site recognized both the growth factor and its signalling receptor, with the 6-sulphates presumably being part of a subsite that bound the receptor. This idea arose because of an earlier suggestion that HS must bind the FGF receptor [22] as well as bFGF so that receptor and ligand would be brought into close proximity.
Heparins fully depleted of 6-sulphate groups were shown to be inhibitors of bFGF [18] .
Because the high-affinity oligo-H sequence (also devoid of 6-sulphates) is a naturally occurring structure in fibroblast HS, it may be a negative regulator of bFGF-driven cell growth, whereas comparable sequences with the necessary complement and positioning of 6-sulphate groups should activate the growth factor. In the case of bFGF, therefore, the message in the HS sequence may be suppressive or stimulatory for growth depending on the structural characteristics of the S-domains expressed on cell surfaces.
Studies on other growth factors including aFGF [18, 23, 24] and hepatocyte growth factor [25] indicate that they have different structural requirements for binding to HS and both of these growth factors seem to recognize 6-sulphate groups as substituents of their binding domains. Differential binding and activation of aFGF and bFGF is observed in HS synthesized at different stages of development of the neuroepithelium [24] . In common with bFGF, hepatocyte growth factor and aFGF also display near optimum binding to S-domains of six to seven disaccharides in length.
Summary
HS influences fundamental cellular properties and biochemical processes at the cell surface. In addition to the issues already discussed, it has a profound effect on cell adhesion and migration through its interaction with many extracellular matrix proteins, most notably fibronectin and thrombospondin; it is closely linked to lipid metabolism through its capacity to bind lowdensity lipoprotein and lipoprotein lipase; and aberrations in HS structure and degradation are linked to human malignancy and Alzheimer's disease [26, 27] . The subtle variations in HS structure enable it to distinguish between families of related proteins such as the FGFs, the chemokines [28] and the TGFBs [29] . The multifunctional nature of HS is the result of its structural diversity and strategic positioning in the pericellular domain. The biosynthesis of HS, in common with other complex carbohydrates, is not directed by any known template yet the system is clearly subject to quite precise control so that in general, the HS family has a common domain organization that is finely tuned at the cellular level to produce HS species of variable length, fine structure and biological properties. A major challenge for future research will be to Volume 
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The Role of Glycosylation in Biomolecular Interactions unravel the regulatory mechanisms that determine the molecular structure of HS. It remains unclear whether these mechanisms are entirely intrinsic in nature or subject to substantial modulation by the cellular microenvironment. 
